2018 Cardiometabolic Health Congress West Agenda

May 4-5, 2018

Wynn Las Vegas

Advancing Cardiometabolic Health from East to West

Friday, May 4, 2018
6:30 - 7:00 am	Registration
7:10 - 8:25 am	CME Breakfast Symposium Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.	Chair: Matthew R. Weir, MD Presenters: Yehuda Handelsman, MD;Lance Sloan, MD
Session I: Obesity and Lifestyle Medicine
8:35 - 8:40 am	Chair Introduction and Opening Remarks	Chair: Robert H. Eckel, MD
8:40 - 9:00 am	Bariatric Surgery - State of the Art	Ninh T. Nguyen, MD
9:00 - 9:20 am	What You Need to Know: Complications of Bariatric Surgery	Daniel H. Bessesen, MD
9:20 - 9:40 am	Cardiovascular/Metabolic Benefits of Bariatric Surgery	Sangeeta R. Kashyap, MD
9:40 - 10:00 am	Panel Discussion and Q&A	Chair: Robert H. Eckel, MD Panel: Daniel H. Bessesen, MD; Sangeeta R. Kashyap, MD; Ninh T. Nguyen, MD
10:05 - 10:35 am	Morning Break & Exhibits
10:40 - 11:10 am	Keynote Presentation Obesity and Inflammation: What have we learned from animal models?	Alan Chait, MD
11:10 - 11:30 am	Benefits of Physical Activity and Exercise on Cardiovascular and Mental Health	Jason R. Tregellas, PhD
11:30 - 11:50 am	Navigating Weight Loss Management in Diabetic Patients with CV Risk	Ken Fujioka, MD
11:50 am - 12:10 pm	Panel Discussion and Q&A	Chair: Robert H. Eckel, MD Panel: Ken Fujioka, MD; Jason R. Tregellas, PhD
12:10 pm	Closing Remarks	Robert H. Eckel, MD
12:20 - 1:35 pm	PME Lunch Symposium (NON-CME) Repatha® (evolocumab): Putting it into Practice Sponsored by Amgen, Inc.	Paul D. Rosenblit, MD, PhD, FACE, FNLA
Session II: Dyslipidemia/Atherosclerosis
1:45 - 1:50 pm	Chair Introduction	Chair: Christie M. Ballantyne, MD
1:50 - 2:10 pm	Advances in Lipid Therapy: Non-statin Drugs and New Approaches	Marc S. Sabatine, MD, MPH
2:10 - 2:30 pm	It’s Time for Consensus: Defining Familial Hypercholesterolemia	Joshua W. Knowles, MD
2:30 - 2:50 pm	Importance of Lifestyle Modifications in Lipid Management	Nancy Houston Miller, RN, BSN
2:55 - 3:25 pm	Afternoon Break & Exhibits
3:30 - 3:50 pm	Updates in Severe Hypertriglyceridemia Treatment	Sotirios Tsimikas, MD
3:50 - 4:10 pm	Navigating the Diagnosis and Treatment of Hypertriglyceridemia in Patients with High CV Risk	Karol Watson, MD
4:10 - 4:30 pm	Integrating Evidence-Based Data and Guidelines into Clinical Practice	Yehuda Handelsman, MD
4:30 - 5:10 pm	Challenging Patient Cases: The Triglyceride Dilemma	Presenters: Robert H. Eckel, MD Christie M. Ballantyne, MD Panel: Yehuda Handelsman, MD; Nancy Houston Miller, RN, BSN; Sotirios Tsimikas, MD; Karol Watson, MD
5:10 - 5:30 pm	Panel Discussion and Q&A	Chair: Christie M. Ballantyne, MD Panel: Robert H. Eckel, MD; Yehuda Handelsman, MD; Nancy Houston Miller, RN, BSN; Sotirios Tsimikas, MD; Karol Watson, MD
5:30 pm	Closing Remarks	Chair: Christie M. Ballantyne, MD
5:35 - 6:35 pm	Networking Reception
6:45 - 8:00 pm	PME Dinner Symposium (NON-CME) Severe Hypertriglyceridemia & Pancreatitis: Including Familial Chylomicronemia Syndrome (FCS) in Your Differential Diagnosis Sponsored by Akcea Therapeutics	Paul D. Rosenblit, MD, PhD, FACE, FNLA

Saturday, May 5, 2018

7:00 - 7:30 am

Registration

7:40 - 8:55 am

CME Breakfast Symposium
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life
Supported by an educational grant from American Regent.

Chair: Clyde W. Yancy, MD

Presenters: Gurushner Panjrath, MD; Biykem Bozkurt, MD

Session III: Heart Failure And Hypertension

9:05 - 9:10 am

Chair Introduction

Chair: Clyde W. Yancy, MD

9:10 - 9:35 am	I. Updates in Hypertension: New BP Guidelines from ACC/AHA and ADA	Matthew R. Weir, MD
9:35 - 9:55 am	II. Challenging Patient Case: Best Approach to Treatment in Patients with CKD, Hypertension, and T2DM	Matthew R. Weir, MD	Matthew R. Weir, MD

9:55 - 10:15 am

Panel Discussion and Q&A

Chair: Clyde W. Yancy, MD
Panel: Matthew R. Weir, MD

10:20 - 10:50 am

Morning Break & Exhibits

10:55 - 11:20 am	I. Risk of Heart Failure in Diabetic Patients	Yehuda Handelsman, MD
11:20 - 11:35 am	II. Challenging Patient Case: Controlling the of Risk Factors for Heart Failure in Patients with Diabetes	Yehuda Handelsman, MD	Yehuda Handelsman, MD

11:35 am - 12:00 pm	I. Approaches to Blood Pressure Control in Heart Failure	Clyde W. Yancy, MD
12:00 - 12:20 pm	II. Integrating BP Control Approaches in A Challenging Heart Failure Patient Case	Clyde W. Yancy, MD	Clyde W. Yancy, MD

12:20 - 12:40 pm

Panel Discussion and Q&A

Chair: Clyde W. Yancy, MD
Panel: Yehuda Handelsman, MD

12:40 pm

Closing Remarks

Chair: Clyde W. Yancy, MD

12:50 - 2:05 pm

CME Lunch Symposium
Updates in Inflammation and Secondary CVD Prevention
Supported by an educational grant from Novartis Pharmaceuticals Corporation

Chair: Christie M. Ballantyne, MD
Presenters:
Ishwarlal Jialal, MD, PhD; Brendan M. Everett, MD

Session IV: Diabetes Management

2:15 - 2:20 pm

Chair Introduction

Chair: Jay S. Skyler, MD

2:20 - 2:50 pm

Updates on CVOTs: Completed and Ongoing

Sanjay Kaul, MD

2:50 - 3:20 pm

SGLT2 Inhibitors: MOAs, Benefits, Outcomes, and Class Effect

Leigh Perreault, MD

3:20 - 3:50 pm